基本信息
浏览量:0
职业迁徙
个人简介
I am a clinical investigator in the Division of Hematologic Malignancies and Cellular Therapy in the Department of Medicine. I serve as Director of the Leukemia Program and Director of Phase I Development in Hematologic Malignancies. I am also the Chair of the SWOG Leukemia Committee. I am interested in the clinical development of novel therapies for acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative neoplasms (such as chronic myeloid leukemia, polycythemia vera, essential thrombocythemia and myelofibrosis), and acute lymphoblastic leukemia. Specifically, I have been the Principal Investigator for small molecular inhibitors, antibody-drug conjugates and cytotoxic chemotherapy.
研究兴趣
论文共 119 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Leukemiano. 1 (2024): 58-66
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): TPS7079-TPS7079
引用0浏览0引用
0
0
Christina M. Termini,Anna Moseley, Megan Othus,Frederick R. Appelbaum,Thomas R. Chauncey,Harry P. Erba, Min Fang,Stanley C. Lee, Jasmine Naru,Era L. Pogosova-Agadjanyan,Jerald P. Radich, Cheryl L. Willman,
HAEMATOLOGICAno. 11 (2023): 3148-3151
The Lancetno. 10393 (2023): 2073-2086
引用9浏览0引用
9
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn